---
title: "Simulated ICU Trajectories After Stroke: Temporal Validation Using MIMIC‑IV"
id: "medrxiv-1-simulation-and-temporal-validation-of-icu-trajectories-after-stroke-patient"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-1-simulation-and-temporal-validation-of-icu-trajectories-after-stroke-patient"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Simulated ICU Trajectories After Stroke: Temporal Validation Using MIMIC‑IV
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-1-simulation-and-temporal-validation-of-icu-trajectories-after-stroke-patient
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators analyzed 6,366 **ICU** stays for **stroke** from the **MIMIC IV** database to describe how ICU time is composed and to test a modular simulator against direct prediction models. - The team classified hourly ICU time into three mutually exclusive categories using readiness criteria: organ support needs, stroke‑specific needs, and hours not explained by those needs. - A frozen hourly simulator was trained on stays up to 2016 and temporally validated on two later partitions: 2017–2019 (n=1,714) and 2020 onwards (n=1,521). - The primary outcome for prediction was the 24‑hour alive exit Brier score compared with a strong direct model (gradient boosting). - Overall unexplained ICU time represented 34.1% of hours in standard ICUs and 87.6% in neuro intermediate units, reflecting differing purposes of units. - The simulator and the gradient boosting model produced nearly identical 24‑hour Brier scores (0.1238 vs 0.1245; reported difference −0.0007 with 95% CI −0.0030 to 0.0016). - The simulator showed better calibration at 48 and 72 hours but lower discrimination (C statistic ~0.71) than the direct model (C statistic ~0.74–0.75). - Investigators observed that readiness was not a single event: 37.8% of stays lost readiness for ≥6 consecutive hours after first confirmation, and many patients remained in ICU long after meeting readiness, especially in neuro intermediate units. - All models overpredicted ICU exit after 2016; the authors attributed most of the temporal error to events occurring after readiness, linked to changing unit mix. - The study team noted that the simulator generates full patient trajectories and matched the strongest direct model in accuracy but requires external validation before clinical use.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Simulation and temporal validation of ICU trajectories after stroke: patient condition, transfer readiness and actual ICU exit [ View ORCID Profile](http://orcid.org/0000-0002-8904-3167)Ping LEI, [ View ORCID Profile](http://orcid.org/0000-0003-0270-2017)Yanyi XU, [ View ORCID Profile](http://orcid.org/0000-0003-4419-7004)Yuxia ZHANG, [ View ORCID Profile](http://orcid.org/0000-0002-4696-5313)Nicolas Ray, [ View ORCID Profile](http://orcid.org/0000-0003-4041-186X)Ying GAO doi: https://doi.org/10.64898/2026.11.17.26368348 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Ping LEI 1 Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Overseas Liaison Department, School of Public Health, Fudan University, Shanghai, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ping%2BLEI%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=LEI%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APing%2BLEI%2B) * [ORCID record for Ping LEI](http://orcid.org/0000-0002-8904-3167 "Open in new tab") * For correspondence: ping.pinglei@unige.ch Yanyi XU 2 Department of Environmental Health, School of Public Health, Fudan University, Shanghai, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yanyi%2BXU%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=XU%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYanyi%2BXU%2B) * [ORCID record for Yanyi XU](http://orcid.org/0000-0003-0270-2017 "Open in new tab") Yuxia ZHANG 3 Department of Nursing, Zhongshan Hospital, Fudan University, Shanghai, China; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuxia%2BZHANG%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=ZHANG%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYuxia%2BZHANG%2B) * [ORCID record for Yuxia ZHANG](http://orcid.org/0000-0003-4419-7004 "Open in new tab") Nicolas Ray 4 University of Geneva Faculty of Medicine: Universite de Geneve Faculte de Medecine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nicolas%2BRay%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ray%20N&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ANicolas%2BRay%2B) * [ORCID record for Nicolas Ray](http://orcid.org/0000-0002-4696-5313 "Open in new tab") Ying GAO 5 National Center for Neurological Disorders, Beijing Tiantan Hospital, Capital Medical University, Beijing, China * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ying%2BGAO%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=GAO%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYing%2BGAO%2B) * [ORCID record for Ying GAO](http://orcid.org/0000-0003-4041-186X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349310/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349310/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349310/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1349310/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349310/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349310/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Objective: To describe how intensive care unit (ICU) time is composed after stroke, and to test whether simulating patient condition, transfer readiness and ICU exit separately predicts as accurately as direct models. Materials and Methods: In 6,366 ICU stays for stroke in MIMIC IV, hourly readiness criteria divided ICU hours into organ support needs, stroke specific needs, and time not explained by these needs. An hourly simulator was built on stays up to 2016, frozen, and validated on 2017 to 2019 (n=1,714) and 2020 onwards (n=1,521). The primary measure was the 24 hour alive exit Brier score versus the strongest direct model (gradient boosting). Results: Unexplained time was 34.1% of hours in standard ICUs and 87.6% in neuro intermediate units. 37.8% of stays lost readiness for ≥6 consecutive hours after first confirmation. The simulator and gradient boosting were indistinguishable (Brier 0.1238 vs 0.1245; difference −0.0007, 95% CI −0.0030 to 0.0016). The simulator was better calibrated at 48 and 72 hours but discriminated less well (C statistic 0.71 vs 0.74 to 0.75). All models overpredicted exit after 2016; the error lay mainly after readiness (median 40 hours simulated vs 68 observed). Discussion: Readiness was not a single event: patients often lost and regained it, and many stayed long after meeting it, especially in neuro intermediate units, which exist for monitoring. Separate modelling did not improve accuracy but placed the post 2016 error after readiness, as the unit mix changed. Conclusion: The simulator matched the strongest direct model while also generating complete trajectories. It needs external validation before any clinical use. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Protocols ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Institutional Review Board of Beth Israel Deaconess Medical Center (Boston, MA, USA) gave ethical approval for this work (the MIMIC-IV database) and waived the requirement for informed consent. This study is a secondary analysis of de-identified data accessed under the PhysioNet Credentialed Health Data Use Agreement. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability MIMIC-IV and MIMIC-IV-ED are available through PhysioNet to credentialed researchers who sign the data use agreement. The data cannot be redistributed by the authors. Analysis code and the locked analysis plans are available on GitHub. The frozen model package will be shared through PhysioNet under credentialed access and is available meanwhile from the corresponding author to investigators with MIMIC-IV access. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.17.26365888v1 "Nonstructural Protein 1 \(NS1\)-based IgG FcγR competition Enzyme-Linked Immunosorbent Assays \(ELISAs\) for highly specific serological profiling of previous flavivirus exposures")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.17.26368266v1 "Automated Gland MRI Radiomics for Predicting Time to Pathologic Progression during Prostate Cancer Active Surveillance") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.17.26368348.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.11.17.26368348v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.17.26368348.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Simulation and temporal validation of ICU trajectories after stroke: patient condition, transfer readiness and actual ICU exit Ping LEI, Yanyi XU, Yuxia ZHANG, Nicolas Ray, Ying GAO medRxiv 2026.11.17.26368348; doi: https://doi.org/10.64898/2026.11.17.26368348 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368348v1%26text%3DSimulation%2520and%2520temporal%2520validation%2520of%2520ICU%2520trajectories%2520after%2520stroke%253A%2520patient%2520condition%252C%2520transfer%2520readiness%2520and%2520actual%2520ICU%2520exit "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368348v1%26t%3DSimulation%2520and%2520temporal%2520validation%2520of%2520ICU%2520trajectories%2520after%2520stroke%253A%2520patient%2520condition%252C%2520transfer%2520readiness%2520and%2520actual%2520ICU%2520exit "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368348v1%26title%3DSimulation%2520and%2520temporal%2520validation%2520of%2520ICU%2520trajectories%2520after%2520stroke%253A%2520patient%2520condition%252C%2520transfer%2520readiness%2520and%2520actual%2520ICU%2520exit%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368348v1%26title%3DSimulation%2520and%2520temporal%2520validation%2520of%2520ICU%2520trajectories%2520after%2520stroke%253A%2520patient%2520condition%252C%2520transfer%2520readiness%2520and%2520actual%2520ICU%2520exit "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368348) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.17.26368348v1&count=horizontal&via=&text=Simulation%20and%20temporal%20validation%20of%20ICU%20trajectories%20after%20stroke%3A%20patient%20condition%2C%20transfer%20readiness%20and%20actual%20ICU%20exit&counturl=www.medrxiv.org/content/10.64898/2026.11.17.26368348v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (927) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5055) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16339) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1248) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7328) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (759) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1101) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5346) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1847) * [Hematology](https://www.medrxiv.org/collection/hematology) (604) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1389) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16534) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1209) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (757) * [Neurology](https://www.medrxiv.org/collection/neurology) (7659) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1142) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1306) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3765) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1105) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (473) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (726) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1877) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (791) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6184) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10047) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2559) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1538) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1280) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (666) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (813) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (809) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (321) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automat
## Related Clinical Research

- [Cerevance names Karl Kieburtz as chief medical officer — Pharmalot update](https://medichelpline.com/clinical-feed/stat-news-0-stat-up-and-down-the-ladder-the-latest-comings-and-goings.md)
- [HHS to fund research on ibogaine for PTSD, STAT reports](https://medichelpline.com/clinical-feed/stat-news-1-stat-hhs-plans-funding-for-research-into-ibogaine-for-ptsd.md)
- [Gland MRI Radiomics Predicts Time to Pathologic Progression on Prostate Cancer Active Surveillance](https://medichelpline.com/clinical-feed/medrxiv-6-automated-gland-mri-radiomics-for-predicting-time-to-pathologic-progression.md)
- [GLP-1 RAs on Top of Statins Linked to Lower Mortality, MI, and Stroke in ASCVD with Obesity](https://medichelpline.com/clinical-feed/medrxiv-0-glp-1-receptor-agonists-added-to-statin-therapy-and-cardiovascular-outcomes-in.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.